| calcium channel, voltage-dependent, alpha 1F subunit |
AJMALINE |
Calcium Channel Type L, Benzothiazepine |
57% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
AJMALINE |
Calcium Channel Type L, Benzothiazepine |
57% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
AJMALINE |
Calcium Channel Type L, Benzothiazepine |
57% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
AJMALINE |
Calcium Channel Type L, Benzothiazepine |
57% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
AJMALINE |
Calcium Channel Type L, Benzothiazepine |
57% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
AJMALINE |
Calcium Channel Type L, Benzothiazepine |
57% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
AJMALINE |
Calcium Channel Type L, Benzothiazepine |
57% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
AJMALINE |
Calcium Channel Type L, Benzothiazepine |
57% |
NoneNone |
NoneNone |
View
|
| estrogen receptor 1 |
LIPOPOLYSACCHARIDE E. COLI O55:B5 |
Estrogen ERalpha |
57% |
NoneNone |
NoneNone |
View
|
| estrogen receptor 1 |
LIPOPOLYSACCHARIDE E. COLI O55:B5 |
Estrogen ERalpha |
57% |
NoneNone |
NoneNone |
View
|
| progesterone receptor |
BETA-ESTRADIOL 3-BENZOATE |
Progesterone |
57% |
9.608uM |
1.253uM |
View
|
| progesterone receptor |
BETA-ESTRADIOL 3-BENZOATE |
Progesterone |
57% |
9.608uM |
1.253uM |
View
|
| acetylcholinesterase (YT blood group) |
RANITIDINE |
Acetylcholinesterase |
57% |
NoneNone |
NoneNone |
View
|
| collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase |
RANITIDINE |
Acetylcholinesterase |
57% |
NoneNone |
NoneNone |
View
|
| acetylcholinesterase |
RANITIDINE |
Acetylcholinesterase |
57% |
NoneNone |
NoneNone |
View
|
| solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
RANITIDINE |
Serotonin Transporter |
57% |
NoneNone |
NoneNone |
View
|
| A3 adenosine receptor |
ALPHA-NAPHTHOFLAVONE |
Adenosine A3 |
57% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 |
COBALT (II) CHLORIDE |
Cyclooxygenase COX-2 |
57% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
COBALT (II) CHLORIDE |
Cyclooxygenase COX-2 |
57% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
VERAPAMIL |
Calcium Channel Type L, Dihydropyridine |
65% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
VERAPAMIL |
Calcium Channel Type L, Dihydropyridine |
65% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
VERAPAMIL |
Calcium Channel Type L, Dihydropyridine |
65% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
VERAPAMIL |
Calcium Channel Type L, Dihydropyridine |
65% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
VERAPAMIL |
Calcium Channel Type L, Dihydropyridine |
65% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
VERAPAMIL |
Calcium Channel Type L, Dihydropyridine |
65% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
VERAPAMIL |
Calcium Channel Type L, Dihydropyridine |
65% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
VERAPAMIL |
Calcium Channel Type L, Dihydropyridine |
65% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
VERAPAMIL |
Calcium Channel Type L, Dihydropyridine |
65% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
VERAPAMIL |
Calcium Channel Type L, Dihydropyridine |
65% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
VERAPAMIL |
Calcium Channel Type L, Dihydropyridine |
65% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
VERAPAMIL |
Calcium Channel Type L, Dihydropyridine |
65% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
VERAPAMIL |
Calcium Channel Type L, Dihydropyridine |
65% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
VERAPAMIL |
Calcium Channel Type L, Dihydropyridine |
65% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
VERAPAMIL |
Calcium Channel Type L, Dihydropyridine |
65% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
VERAPAMIL |
Calcium Channel Type L, Dihydropyridine |
65% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
VERAPAMIL |
Calcium Channel Type L, Dihydropyridine |
65% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
VERAPAMIL |
Calcium Channel Type L, Dihydropyridine |
65% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
VERAPAMIL |
Calcium Channel Type L, Dihydropyridine |
65% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
VERAPAMIL |
Calcium Channel Type L, Dihydropyridine |
65% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 |
IDEBENONE |
Cyclooxygenase COX-1 |
65% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
IDEBENONE |
Cyclooxygenase COX-1 |
65% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
FELODIPINE |
Calcium Channel Type L, Phenylalkylamine |
65% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
FELODIPINE |
Calcium Channel Type L, Phenylalkylamine |
65% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
FELODIPINE |
Calcium Channel Type L, Phenylalkylamine |
65% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
FELODIPINE |
Calcium Channel Type L, Phenylalkylamine |
65% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
FELODIPINE |
Calcium Channel Type L, Phenylalkylamine |
65% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
FELODIPINE |
Calcium Channel Type L, Phenylalkylamine |
65% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
FELODIPINE |
Calcium Channel Type L, Phenylalkylamine |
65% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
FELODIPINE |
Calcium Channel Type L, Phenylalkylamine |
65% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
FELODIPINE |
Calcium Channel Type L, Phenylalkylamine |
65% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
FELODIPINE |
Calcium Channel Type L, Phenylalkylamine |
65% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
FELODIPINE |
Calcium Channel Type L, Phenylalkylamine |
65% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
FELODIPINE |
Calcium Channel Type L, Phenylalkylamine |
65% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
FELODIPINE |
Calcium Channel Type L, Phenylalkylamine |
65% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
FELODIPINE |
Calcium Channel Type L, Phenylalkylamine |
65% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
FELODIPINE |
Calcium Channel Type L, Phenylalkylamine |
65% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
FELODIPINE |
Calcium Channel Type L, Phenylalkylamine |
65% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
FELODIPINE |
Calcium Channel Type L, Phenylalkylamine |
65% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
FELODIPINE |
Calcium Channel Type L, Phenylalkylamine |
65% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
FELODIPINE |
Calcium Channel Type L, Phenylalkylamine |
65% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
FELODIPINE |
Calcium Channel Type L, Phenylalkylamine |
65% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 5A, cGMP-specific |
RWJ-68354 |
Phosphodiesterase PDE5 |
65% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 5A, cGMP-specific |
RWJ-68354 |
Phosphodiesterase PDE5 |
65% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-2C19 monooxygenase |
MITOTANE |
CYP450-2C19 Inhibition |
65% |
NoneNone |
NoneNone |
View
|
| protein tyrosine phosphatase, receptor type, C |
MITOXANTRONE |
Protein Tyrosine Phosphatase, CD45 |
65% |
NoneNone |
NoneNone |
View
|
| protein tyrosine phosphatase, receptor type, C |
MITOXANTRONE |
Protein Tyrosine Phosphatase, CD45 |
65% |
NoneNone |
NoneNone |
View
|
| opioid receptor, sigma 1 |
NORETHINDRONE ACETATE |
Sigma1 |
65% |
NoneNone |
NoneNone |
View
|
| potassium voltage-gated channel, subfamily H (eag-related), member 4 |
MYRTECAINE |
Potassium Channel HERG |
65% |
5.9024uM |
4.8357uM |
View
|
| sodium channel, voltage-gated, type IV, beta |
VINORELBINE |
Sodium Channel, Site 2 |
64% |
5.202uM |
4.746uM |
View
|
| sodium channel, voltage-gated, type IV, alpha |
VINORELBINE |
Sodium Channel, Site 2 |
64% |
5.202uM |
4.746uM |
View
|
| sodium channel, voltage-gated, type III, alpha |
VINORELBINE |
Sodium Channel, Site 2 |
64% |
5.202uM |
4.746uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
METERGOLINE |
Calcium Channel Type L, Dihydropyridine |
64% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
METERGOLINE |
Calcium Channel Type L, Dihydropyridine |
64% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
METERGOLINE |
Calcium Channel Type L, Dihydropyridine |
64% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
METERGOLINE |
Calcium Channel Type L, Dihydropyridine |
64% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
METERGOLINE |
Calcium Channel Type L, Dihydropyridine |
64% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
METERGOLINE |
Calcium Channel Type L, Dihydropyridine |
64% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
METERGOLINE |
Calcium Channel Type L, Dihydropyridine |
64% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
METERGOLINE |
Calcium Channel Type L, Dihydropyridine |
64% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
METERGOLINE |
Calcium Channel Type L, Dihydropyridine |
64% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
METERGOLINE |
Calcium Channel Type L, Dihydropyridine |
64% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
METERGOLINE |
Calcium Channel Type L, Dihydropyridine |
64% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
METERGOLINE |
Calcium Channel Type L, Dihydropyridine |
64% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
METERGOLINE |
Calcium Channel Type L, Dihydropyridine |
64% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
METERGOLINE |
Calcium Channel Type L, Dihydropyridine |
64% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
METERGOLINE |
Calcium Channel Type L, Dihydropyridine |
64% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 |
PHENELZINE |
Cyclooxygenase COX-1 |
64% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
PHENELZINE |
Cyclooxygenase COX-1 |
64% |
NoneNone |
NoneNone |
View
|
| histamine receptor H 2 |
PROCHLORPERAZINE |
Histamine H2 |
64% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 1 |
FLUVASTATIN |
Protein Serine/Threonine Kinase, ERK2 |
64% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 1 |
FLUVASTATIN |
Protein Serine/Threonine Kinase, ERK2 |
64% |
NoneNone |
NoneNone |
View
|
| angiotensin II receptor, type 2 |
MICONAZOLE |
Angiotensin AT2 |
64% |
23.986uM |
7.779uM |
View
|
| Sigma-2 Receptor |
VECURONIUM BROMIDE |
Sigma2 |
64% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 1b |
KETOCONAZOLE |
Adrenergic alpha1B |
64% |
22.91uM |
12.683uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
FENOFIBRATE |
Calcium Channel Type L, Phenylalkylamine |
64% |
17.746uM |
17.253uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
FENOFIBRATE |
Calcium Channel Type L, Phenylalkylamine |
64% |
17.746uM |
17.253uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
FENOFIBRATE |
Calcium Channel Type L, Phenylalkylamine |
64% |
17.746uM |
17.253uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
FENOFIBRATE |
Calcium Channel Type L, Phenylalkylamine |
64% |
17.746uM |
17.253uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
FENOFIBRATE |
Calcium Channel Type L, Phenylalkylamine |
64% |
17.746uM |
17.253uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
FENOFIBRATE |
Calcium Channel Type L, Phenylalkylamine |
64% |
17.746uM |
17.253uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
FENOFIBRATE |
Calcium Channel Type L, Phenylalkylamine |
64% |
17.746uM |
17.253uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
FENOFIBRATE |
Calcium Channel Type L, Phenylalkylamine |
64% |
17.746uM |
17.253uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
FENOFIBRATE |
Calcium Channel Type L, Phenylalkylamine |
64% |
17.746uM |
17.253uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
FENOFIBRATE |
Calcium Channel Type L, Phenylalkylamine |
64% |
17.746uM |
17.253uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
FENOFIBRATE |
Calcium Channel Type L, Phenylalkylamine |
64% |
17.746uM |
17.253uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
FENOFIBRATE |
Calcium Channel Type L, Phenylalkylamine |
64% |
17.746uM |
17.253uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
FENOFIBRATE |
Calcium Channel Type L, Phenylalkylamine |
64% |
17.746uM |
17.253uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
FENOFIBRATE |
Calcium Channel Type L, Phenylalkylamine |
64% |
17.746uM |
17.253uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
FENOFIBRATE |
Calcium Channel Type L, Phenylalkylamine |
64% |
17.746uM |
17.253uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
FENOFIBRATE |
Calcium Channel Type L, Phenylalkylamine |
64% |
17.746uM |
17.253uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
FENOFIBRATE |
Calcium Channel Type L, Phenylalkylamine |
64% |
17.746uM |
17.253uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
FENOFIBRATE |
Calcium Channel Type L, Phenylalkylamine |
64% |
17.746uM |
17.253uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
FENOFIBRATE |
Calcium Channel Type L, Phenylalkylamine |
64% |
17.746uM |
17.253uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
FENOFIBRATE |
Calcium Channel Type L, Phenylalkylamine |
64% |
17.746uM |
17.253uM |
View
|
| opioid receptor, delta 1 |
SULCONAZOLE |
Opiate delta |
64% |
NoneNone |
NoneNone |
View
|
| solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
DANAZOL |
Serotonin Transporter |
64% |
15.42uM |
8.193uM |
View
|
| phosphodiesterase 4A, cAMP specific |
LY-294002 |
Phosphodiesterase PDE4 |
64% |
10.404uM |
NoneNone |
View
|
| epidermal growth factor receptor |
CATECHOL |
Protein Tyrosine Kinase, EGF Receptor |
63% |
26.043uM |
NoneNone |
View
|
| Cytochrom P450-2C19 monooxygenase |
DIHYDROERGOTAMINE |
CYP450-2C19 Inhibition |
63% |
NoneNone |
NoneNone |
View
|
| opioid receptor, sigma 1 |
PREGNENOLONE-16ALPHA-CARBONITRILE |
Sigma1 |
63% |
21.3uM |
8.953uM |
View
|
| adrenergic receptor, beta 3 |
DIHYDROERGOTAMINE |
Adrenergic beta3 |
63% |
NoneNone |
NoneNone |
View
|
| lymphocyte protein tyrosine kinase (mapped) |
TAMOXIFEN |
Protein Tyrosine Kinase, Lck |
63% |
8.033uM |
NoneNone |
View
|
| adrenergic receptor, alpha 1a |
ERGONOVINE |
Adrenergic alpha1A |
63% |
NoneNone |
NoneNone |
View
|
| epidermal growth factor receptor |
BENZBROMARONE |
Protein Tyrosine Kinase, EGF Receptor |
63% |
NoneNone |
NoneNone |
View
|
| cannabinoid receptor 1 (brain) |
FLUOXETINE |
Cannabinoid CB1 |
63% |
NoneNone |
NoneNone |
View
|
| adenosine A2a receptor |
CAFFEINE |
Adenosine A2A |
63% |
20.472uM |
11.493uM |
View
|
| adrenergic receptor, alpha 1b |
DEXTROMETHORPHAN |
Adrenergic alpha1B |
63% |
NoneNone |
NoneNone |
View
|
| A3 adenosine receptor |
FLUPHENAZINE |
Adenosine A3 |
63% |
11.935uM |
6.746uM |
View
|
| Cytochrom P450-2C19 monooxygenase |
DICUMAROL |
CYP450-2C19 Inhibition |
63% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 4A, cAMP specific |
DICUMAROL |
Phosphodiesterase PDE4 |
63% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 4C, cAMP-specific |
DICUMAROL |
Phosphodiesterase PDE4 |
63% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 4D |
DICUMAROL |
Phosphodiesterase PDE4 |
63% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 4B, cAMP specific |
DICUMAROL |
Phosphodiesterase PDE4 |
63% |
NoneNone |
NoneNone |
View
|
| adenosine A1 receptor |
FLAVOXATE |
Adenosine A1 |
63% |
NoneNone |
NoneNone |
View
|
| epidermal growth factor receptor |
SULINDAC SULFIDE |
Protein Tyrosine Kinase, EGF Receptor |
63% |
23.981uM |
NoneNone |
View
|
| adrenergic receptor, alpha 2a |
GENTIAN VIOLET |
Imidazoline I2, Central |
63% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
GENTIAN VIOLET |
Imidazoline I2, Central |
63% |
NoneNone |
NoneNone |
View
|
| lymphocyte protein tyrosine kinase (mapped) |
CISPLATIN |
Protein Tyrosine Kinase, Lck |
63% |
22.949uM |
NoneNone |
View
|
| solute carrier family 28 (sodium-coupled nucleoside transporter), member 3 |
BROMOCRIPTINE |
Adenosine Transporter |
63% |
NoneNone |
NoneNone |
View
|
| concentrative Na+ nucleoside cotransporter (DBSS) |
BROMOCRIPTINE |
Adenosine Transporter |
63% |
NoneNone |
NoneNone |
View
|
| solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 |
BROMOCRIPTINE |
Adenosine Transporter |
63% |
NoneNone |
NoneNone |
View
|
| adenine nucleotide translocase (DBSS) (Non-specific probe) |
BROMOCRIPTINE |
Adenosine Transporter |
63% |
NoneNone |
NoneNone |
View
|
| solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 |
BROMOCRIPTINE |
Adenosine Transporter |
63% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 2b |
MEPAZINE |
Adrenergic alpha2C |
63% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
MEPAZINE |
Adrenergic alpha2C |
63% |
NoneNone |
NoneNone |
View
|
| lymphocyte protein tyrosine kinase (mapped) |
ZIRCONIUM(IV) CHLORIDE |
Protein Tyrosine Kinase, Lck |
63% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, muscarinic 3 |
MITOXANTRONE |
Muscarinic M3 |
63% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 2b |
MITOTANE |
Adrenergic alpha2C |
63% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
MITOTANE |
Adrenergic alpha2C |
63% |
NoneNone |
NoneNone |
View
|
| progesterone receptor |
MITOTANE |
Progesterone |
63% |
NoneNone |
NoneNone |
View
|
| progesterone receptor |
MITOTANE |
Progesterone |
63% |
NoneNone |
NoneNone |
View
|
| angiotensin II receptor, type 2 |
L-744832 |
Angiotensin AT2 |
63% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine receptor 6 |
RISPERIDONE |
Serotonin 5-HT6 |
63% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-1A2 monooxygenase |
ROFECOXIB |
CYP450-1A2 Inhibition |
63% |
NoneNone |
NoneNone |
View
|
| dopamine receptor D4 |
OLANZAPINE |
Dopamine D4.2 |
63% |
NoneNone |
NoneNone |
View
|
| cytochrome P450, family 3, subfamily a, polypeptide 13 |
DICYCLOMINE |
CYP450-3A4 Inhibition |
63% |
NoneNone |
NoneNone |
View
|
| cytochrome P450, family 3, subfamily a, polypeptide 13 |
NOSCAPINE |
CYP450-3A4 Inhibition |
63% |
NoneNone |
NoneNone |
View
|
| A3 adenosine receptor |
3,3',5-TRIIODO-L-THYRONINE |
Adenosine A3 |
63% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2B |
BETA-NAPHTHOFLAVONE |
Serotonin 5-HT2B |
63% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2C |
PERHEXILINE |
Serotonin 5-HT2C |
63% |
NoneNone |
NoneNone |
View
|
| dopamine receptor D4 |
SULOCTIDIL |
Dopamine D4.2 |
63% |
NoneNone |
NoneNone |
View
|
| solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
PERHEXILINE |
Dopamine Transporter |
63% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-1A2 monooxygenase |
RILUZOLE |
CYP450-1A2 Inhibition |
63% |
NoneNone |
NoneNone |
View
|
| Sigma-2 Receptor |
PROPAFENONE |
Sigma2 |
63% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, muscarinic 2 |
IMATINIB |
Muscarinic M2 |
63% |
NoneNone |
NoneNone |
View
|
| cytochrome P450, family 3, subfamily a, polypeptide 13 |
VERAPAMIL |
CYP450-3A4 Inhibition |
63% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-2D6 monooxygenase |
RAPAMYCIN |
CYP450-2D6 Inhibition |
63% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-2D6 monooxygenase |
RESVERATROL |
CYP450-2D6 Inhibition |
63% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-2C19 monooxygenase |
CLOSANTEL |
CYP450-2C19 Inhibition |
63% |
NoneNone |
NoneNone |
View
|
| solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
3,3',4',5-TETRACHLOROSALICYLANILIDE |
Adrenergic, Norepinephrine Transporter |
63% |
NoneNone |
NoneNone |
View
|
| A3 adenosine receptor |
ETHYLESTRENOL |
Adenosine A3 |
63% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 1A |
AMITRAZ |
Serotonin 5-HT1A |
63% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 2a |
DOBUTAMINE |
Adrenergic alpha2A |
63% |
NoneNone |
NoneNone |
View
|
| melanocortin 4 receptor |
DIGITONIN |
Melanocortin MC4 |
63% |
NoneNone |
NoneNone |
View
|
| dopamine receptor 2 |
BENZTROPINE |
Dopamine D2L |
63% |
NoneNone |
NoneNone |
View
|
| dopamine receptor D1A |
BENZTROPINE |
Dopamine D1 |
63% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2A |
SPIRADOLINE |
Serotonin 5-HT2A |
63% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine receptor 6 |
QUETIAPINE |
Serotonin 5-HT6 |
63% |
NoneNone |
NoneNone |
View
|
| opioid receptor, delta 1 |
PAROXETINE |
Opiate delta |
63% |
NoneNone |
NoneNone |
View
|
| opioid receptor, kappa 1 |
NELFINAVIR |
Opiate kappa |
63% |
35.996uM |
14.398uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
MIFEPRISTONE |
Calcium Channel Type L, Benzothiazepine |
62% |
29.049uM |
25.821uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
MIFEPRISTONE |
Calcium Channel Type L, Benzothiazepine |
62% |
29.049uM |
25.821uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
MIFEPRISTONE |
Calcium Channel Type L, Benzothiazepine |
62% |
29.049uM |
25.821uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
MIFEPRISTONE |
Calcium Channel Type L, Benzothiazepine |
62% |
29.049uM |
25.821uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2B |
ESTRONE |
Serotonin 5-HT2B |
62% |
13.63uM |
8.676uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
BETA-ESTRADIOL |
Dopamine Transporter |
62% |
14.911uM |
11.847uM |
View
|
| progesterone receptor |
MESTRANOL |
Progesterone |
62% |
84.414uM |
11.01uM |
View
|
| progesterone receptor |
MESTRANOL |
Progesterone |
62% |
84.414uM |
11.01uM |
View
|
| cholinergic receptor, muscarinic 5 |
4-OCTYLPHENOL |
Muscarinic M5 |
62% |
30.764uM |
22.102uM |
View
|
| Cytochrom P450-1A2 monooxygenase |
MESTRANOL |
CYP450-1A2 Inhibition |
62% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type III, alpha |
CELECOXIB |
Sodium Channel, Site 2 |
62% |
16.854uM |
15.111uM |
View
|
| sodium channel, voltage-gated, type II, beta |
CELECOXIB |
Sodium Channel, Site 2 |
62% |
16.854uM |
15.111uM |
View
|
| sodium channel, voltage-gated, type II, alpha 2 |
CELECOXIB |
Sodium Channel, Site 2 |
62% |
16.854uM |
15.111uM |
View
|
| sodium channel, voltage-gated, type I, beta |
CELECOXIB |
Sodium Channel, Site 2 |
62% |
16.854uM |
15.111uM |
View
|
| sodium channel, voltage-gated, type I, alpha |
CELECOXIB |
Sodium Channel, Site 2 |
62% |
16.854uM |
15.111uM |
View
|
| sodium channel, voltage-gated, type IV, beta |
CELECOXIB |
Sodium Channel, Site 2 |
62% |
16.854uM |
15.111uM |
View
|
| sodium channel associated protein 1 |
CELECOXIB |
Sodium Channel, Site 2 |
62% |
16.854uM |
15.111uM |
View
|
| sodium channel associated protein 2 |
CELECOXIB |
Sodium Channel, Site 2 |
62% |
16.854uM |
15.111uM |
View
|
| sodium channel, voltage-gated, type III, beta |
CELECOXIB |
Sodium Channel, Site 2 |
62% |
16.854uM |
15.111uM |
View
|
| sodium channel, voltage-gated, type I, alpha |
CELECOXIB |
Sodium Channel, Site 2 |
62% |
16.854uM |
15.111uM |
View
|